Highlights from this Publication

• “The majority of patients found it easy-to-use and felt that most patients would be able to learn how to use it quickly without the support of an assisting person.”
• “Eighty-five percent of patients agreed to use the IBDoc in the future.”
• “This study also showed a good correlation between the FC measurements from the IBDoc and the ELISA method, with no false positives or negatives…”
• “This study further strengthens the evidence of accuracy of the IBDoc, a home-based FC monitoring kit, and demonstrates that this technology is acceptable to patients to use. It may therefore enable clinicians to more easily adopt a treat-to-target approach, improve long-term outcomes and patients’ quality of life with IBD…”